blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0595467

EP0595467 - Process for preparing antifolate 4-hydroxypyrrolo 2,3-d pyrimidine derivatives [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  18.05.2001
Database last updated on 05.10.2024
Most recent event   Tooltip18.05.2001No opposition filed within time limitpublished on 04.07.2001 [2001/27]
Applicant(s)For all designated states
ELI LILLY AND COMPANY
Lilly Corporate Center
Indianapolis, IN 46285 / US
[N/P]
Former [1994/18]For all designated states
ELI LILLY AND COMPANY
Lilly Corporate Center
Indianapolis, Indiana 46285 / US
Inventor(s)01 / Barnett, Charles Jackson
7540 North Pennsylvania
Indianapolis, Indiana 46240 / US
02 / Wilson, Thomas Michael
1193 Greenlawn
Speedway, Indiana 46224 / US
[1994/18]
Representative(s)Hudson, Christopher Mark, et al
Lilly Industries Limited European Patent Operations Erl Wood Manor Windlesham
Surrey GU20 6PH / GB
[N/P]
Former [1994/18]Hudson, Christopher Mark, et al
Lilly Industries Limited European Patent Operations Erl Wood Manor
Windlesham Surrey GU20 6PH / GB
Application number, filing date93307594.724.09.1993
[1994/18]
Priority number, dateUS1992095148325.09.1992         Original published format: US 951483
[1994/18]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0595467
Date:04.05.1994
Language:EN
[1994/18]
Type: A3 Search report 
No.:EP0595467
Date:22.06.1994
Language:EN
[1994/25]
Type: B1 Patent specification 
No.:EP0595467
Date:19.07.2000
Language:EN
[2000/29]
Search report(s)(Supplementary) European search report - dispatched on:EP03.05.1994
ClassificationIPC:C07D487/04, // (C07D487/04, 239:00, 209:00)
[1994/18]
CPC:
C07D487/04 (EP,US); A61P3/00 (EP); A61P35/00 (EP);
Y02P20/55 (EP,US)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   NL,   PT,   SE [1994/18]
TitleGerman:Verfahren zur Herstellung von Antifolaten 4-Hydroxypyrrolo 2,3-d pyrimidinderivaten[1994/18]
English:Process for preparing antifolate 4-hydroxypyrrolo 2,3-d pyrimidine derivatives[1994/18]
French:Procédé pour la préparation de dérives antifolates de la 4-hydroxypyrrolo 2,3-d pyrimidine[1994/18]
Examination procedure02.10.1993Examination requested  [1994/18]
18.05.1998Despatch of a communication from the examining division (Time limit: M04)
04.09.1998Reply to a communication from the examining division
01.06.1999Despatch of communication of intention to grant (Approval: Yes)
06.09.1999Communication of intention to grant the patent
08.11.1999Fee for grant paid
08.11.1999Fee for publishing/printing paid
Opposition(s)20.04.2001No opposition filed within time limit [2001/27]
Fees paidRenewal fee
07.07.1995Renewal fee patent year 03
26.07.1996Renewal fee patent year 04
21.07.1997Renewal fee patent year 05
04.07.1998Renewal fee patent year 06
10.09.1999Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]EP0402903  (TAKEDA CHEMICAL INDUSTRIES LTD [JP]) [A] 1* page 5, line 43 - line 49; claim 1 *
 [A]  - J.A. SECRIST III ET AL., "Studies directed toward a total synthesis of nucleoside Q. The annulation of 2,6-diaminopyrimidin-4-one with alpha-halo carbonyls to form pyrrolo[2,3-d]pyrimidines and furo[2,3-d]pyrimidines", JOURNAL OF ORGANIC CHEMISTRY, EASTON US, (1978), vol. 43, no. 20, pages 3937 - 3941 [A] 1 * page 3937, column 1, paragraph 2 - column 2, paragraph 1; page 3941, column 1, compound 7 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.